Multiple Sclerosis Research Review Issue 88
In this issue:
Broad rim lesions as a potential biomarker for rapid MS progression
Asymptomatic T2 hyperintense cervical spinal cord lesions in RRMS
Suboptimal B-cell depletion & PIRA with ocrelizumab
Earlier age of MS onset & diagnosis in Asian patients
KFLC-index to differentiate MS from other inflammatory demyelinating diseases
Natalizumab vs. anti-CD20 therapies in RRMS
Natalizumab vs. interferon β-1a in SPMS
POINT: ponesimod + DMF in relapsing MS
Elezanumab + standard of care in relapsing/progressive MS
Prognostic biomarkers for MS in RIS
Expert contributor
Clinical Professor Todd Hardy
Clinical Professor Todd Hardy is Staff Specialist Neurologist at Concord Hospital, Clinical Senior Lecturer in Medicine at the University of Sydney and Co-Director of the MS Clinic at the Brain & Mind Centre. Dr Hardy’s clinical and research interests are in the field of neuroimmunology. His main focus is on multiple sclerosis, including atypical forms […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.